Stock-Based Compensation (Tables)

3 Months Ended

May 01, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Compensation Costs

The compensation costs that have been charged against income were as follows (in thousands):

	13-Weeks Ended
	May 1, 2021		May 2, 2020
Stock-based compensation expense by type:
Stock options	$	174	$	90
Restricted stock units	1,788		1,060
Employee stock purchases	85		44
Director deferred compensation	6		23
Total stock-based compensation expense	2,053		1,217
Income tax benefit recognized	479		391
Stock-based compensation expense, net of income tax	$	1,574	$	826

Schedule of Equity Awards Granted

We have granted the following equity awards:

	13-Weeks Ended
	May 1, 2021	May 2, 2020
Stock options	4,384	27,000
Restricted stock unit awards	61,241	334,485
Performance-based restricted stock unit awards	22,492	—
Deferred stock units	84	2,143

Schedule of Shares Purchased

The number of shares purchased, the average price per share, and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:

	13-Weeks Ended
	May 1, 2021		May 2, 2020
Shares purchased	7,445		17,758
Average price per share	$	39.25	$	9.29
Weighted-average fair value at grant date	$	11.45	$	4.21